Sanofi stock pre-market after a 2.32 percent Paris gain
Published on 09/15/2026 at 08:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi stock closed at EUR 74.96 on Euronext Paris on September 14, 2026, up 2.32 percent. The move left the shares above the prior close of EUR 73.26 and ahead of the broader Paris market, where the CAC 40 fell 0.76 percent to 8,117.78 points.
September 14, 2026 in numbers
Sanofi AG (ISIN FR0000127771) traded between EUR 74.20 and EUR 75.48 during the session, with volume of 1.8 million shares. The close sat 1.03 percent below the 52-week high and 9.44 percent above the 52-week low, giving the session a clear upside comparison versus the index.
As GlobeNewswire reported on September 14, 2026, Sanofi and Cheplapharm announced a partnership covering 20 mature medicines and three manufacturing sites in exchange for a 26.4 percent stake in Cheplapharm. The company said the transaction is not expected to affect its 2026 guidance.
Today in focus
The partnership announcement remains the main corporate item for today. The first phase of the medicine transfer is planned for the first quarter of 2027, and the full transaction is expected to complete in the third quarter of 2027.
